It did not change the recommendation for people who received the Johnson & Johnson vaccine
On Tuesday, the US Centers for Disease Control and Prevention recommended reducing the interval between the second dose of the Pfizer-Biontech vaccine once morest Covid-19 and the booster dose to 5 months instead of 6.
This step comes in the wake of the US Food and Drug Administration’s decision, Monday, to reduce the time between the second and booster doses, and to allow the use of a third dose of the Pfizer-Biontech vaccine for children 12 to 15 years old.
The centers also recommended that children with weak immunity in any way and between the ages of 5 and 11 years receive an additional dose of the vaccine 28 days following the second dose, according to Sky News.
The Pfizer-Biontech vaccine is the only one available for children aged 5 to 11 years in the United States, and it was authorized by the US Food and Drug Administration in late October last year.
The US Centers for Disease Control and Prevention did not change the recommendation regarding the interval between the second and booster doses for people who received the Johnson & Johnson vaccine or Moderna, which remains at two months for the Johnson vaccine, and 6 months for Moderna.
Reducing the interval.. Urgent recommendation regarding the booster dose of “Pfizer”
Sabq electronic newspaper
already
2022-01-05
On Tuesday, the US Centers for Disease Control and Prevention recommended reducing the interval between the second dose of the Pfizer-Biontech vaccine once morest Covid-19 and the booster dose to 5 months instead of 6.
This step comes in the wake of the US Food and Drug Administration’s decision, Monday, to reduce the time between the second and booster doses, and to allow the use of a third dose of the Pfizer-Biontech vaccine for children 12 to 15 years old.
The centers also recommended that children with weak immunity in any way and between the ages of 5 and 11 years receive an additional dose of the vaccine 28 days following the second dose, according to Sky News.
The Pfizer-Biontech vaccine is the only one available for children aged 5 to 11 years in the United States, and it was authorized by the US Food and Drug Administration in late October last year.
The US Centers for Disease Control and Prevention did not change the recommendation regarding the interval between the second and booster doses for people who received the Johnson & Johnson vaccine or Moderna, which remains at two months for the Johnson vaccine, and 6 months for Moderna.
05 January 2022 – 2 Jumada Al-Thani 1443
09:54 AM
It did not change the recommendation for people who received the Johnson & Johnson vaccine
On Tuesday, the US Centers for Disease Control and Prevention recommended reducing the interval between the second dose of the Pfizer-Biontech vaccine once morest Covid-19 and the booster dose to 5 months instead of 6.
This step comes in the wake of the US Food and Drug Administration’s decision, Monday, to reduce the time between the second and booster doses, and to allow the use of a third dose of the Pfizer-Biontech vaccine for children 12 to 15 years old.
The centers also recommended that children with weak immunity in any way and between the ages of 5 and 11 years receive an additional dose of the vaccine 28 days following the second dose, according to Sky News.
The Pfizer-Biontech vaccine is the only one available for children aged 5 to 11 years in the United States, and it was authorized by the US Food and Drug Administration in late October last year.
The US Centers for Disease Control and Prevention did not change the recommendation regarding the interval between the second and booster doses for people who received the Johnson & Johnson vaccine or Moderna, which remains at two months for the Johnson vaccine, and 6 months for Moderna.
